NCT Number: NCT00125125
Fluvastatin in Adults With Dislipidemia With History of Muscle Problems
The purpose of the study is to find a good therapy for patients who need to be treated for high cholesterol and who have difficulty tolerating other statins (such as pravastatin, simvastatin, lovastatin, atorvastatin, rosuvastatin) due to muscle pain.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 4
Primary location
Investigative Centers, Germany
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Dyslipidemia
- History of Myalgia
Exclusion criteria
- Previous treatment with fluvastatin
- Age < 18 years
Other protocol-defined inclusion and exclusion criteria may apply.
Treatment and study plan
Primary outcomes
-
Change from baseline in low density lipoprotein cholesterol after 12 weeks
Secondary outcomes
-
Tolerability as assessed by muscle-related adverse events, and muscle-related adverse events leading to discontinuation
-
Change from baseline in total cholesterol, triglycerides, high density lipoprotein cholesterol, and lipoprotein subtypes after 12 weeks
-
Number of patients who reach target LDL after 12 weeks
-
Change from baseline in marker of inflammation after 12 weeks
Sponsors and collaborators
Lead sponsor
Novartis
Industry
Registry information
Official study title
Efficacy and Tolerability of Fluvastatin in Adults With Dislipidemia With History of Muscle Problems Due to Other Previous Statin Intake
Important dates
- Study start
- 2005
- Primary completion
- 2005
- Study completion
- 2005
- First posted
- Jul 29, 2005
- Registry last updated
- May 17, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C716 and C716R in Healthy Adults
NCT07655960
Dyslipidemia, Dyslipidemias
Seoul, South Korea
View Trial DetailsStudy to Evaluate the Safety and the Pharmacokinetics of "UI111" and "UIC202006" Under Fed Conditions
NCT07691268
Dyslipidemia, Dyslipidemias
Seoul, Gwanak-gu 08779, South Korea
View Trial DetailsPolyunsaturated Fatty Acids-based Bars Effect on Metabolic Syndrome Patients
NCT07627555
Cardiovascular Diseases, Dyslipidemia
Lahore, Pakistan
View Trial DetailsLipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins
NCT00001154
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemia
Bethesda, Maryland, United States
View Trial Details